These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38702995)

  • 1. AI-based and LC-OCT-guided follow-up of actinic keratoses under treatment with tirbanibulin 1.
    Thamm JR; Welzel J; Schuh S
    J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38702995
    [No Abstract]   [Full Text] [Related]  

  • 2. 1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.
    Dao DD; Sahni VN; Sahni DR; Balogh EA; Grada A; Feldman SR
    Ann Pharmacother; 2022 Apr; 56(4):494-500. PubMed ID: 34301153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
    Blauvelt A; Kempers S; Lain E; Schlesinger T; Tyring S; Forman S; Ablon G; Martin G; Wang H; Cutler DL; Fang J; Kwan MR;
    N Engl J Med; 2021 Feb; 384(6):512-520. PubMed ID: 33567191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-based PRO score assessment in actinic keratoses from LC-OCT imaging using Convolutional Neural Networks.
    Thamm JR; Daxenberger F; Viel T; Gust C; Eijkenboom Q; French LE; Welzel J; Sattler EC; Schuh S
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1359-1366. PubMed ID: 37707430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.
    Pellacani G; Schlesinger T; Bhatia N; Berman B; Lebwohl M; Cohen JL; Patel GK; Kunstfeld R; Hadshiew I; Lear JT
    J Eur Acad Dermatol Venereol; 2024 Jan; 38 Suppl 1():3-15. PubMed ID: 38116638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.
    Campione E; Rivieccio A; Gaeta Shumak R; Costanza G; Cosio T; Lambiase S; Garofalo V; Artosi F; Lozzi F; Freni C; Romeo A; Dika E; Falconi M; Bianchi L
    Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tirbanibulin: A New Topical Therapy for Actinic Keratoses With a Novel Mechanism of Action and Improved Ease of Use.
    Gilchrest BA
    Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1126-1129. PubMed ID: 34612001
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm
    DuBois J; Jones TM; Lee MS; Falqués M; Kiyasova V; Jiménez G; Otero R; Jansat JM; Aubets J; Forconi RJ
    Clin Pharmacol Drug Dev; 2024 Feb; 13(2):208-218. PubMed ID: 38185925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis.
    Yavel R; Overcash JS; Cutler D; Fang J; Zhi J
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):397-405. PubMed ID: 34783452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tirbanibulin: Topical Treatment for Actinic Keratosis.
    Dlott AH; Di Pasqua AJ; Spencer SA
    Clin Drug Investig; 2021 Sep; 41(9):751-755. PubMed ID: 34351607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.
    Mansilla-Polo M; Abril-Pérez C; Martín-Torregrosa D; López-Davia J; de Unamuno-Bustos B; Torres-Navarro I; Escutia-Muñoz B; Botella-Estrada R
    Australas J Dermatol; 2023 Nov; 64(4):560-564. PubMed ID: 37675890
    [No Abstract]   [Full Text] [Related]  

  • 12. Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
    Kempers S; DuBois J; Forman S; Poon A; Cutler E; Wang H; Cutler D; Fang J; Kwan R
    J Drugs Dermatol; 2020 Nov; 19(11):1093-1100. PubMed ID: 33196758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused update: Guidelines of care for the management of actinic keratosis.
    Eisen DB; Dellavalle RP; Frazer-Green L; Schlesinger TE; Shive M; Wu PA
    J Am Acad Dermatol; 2022 Aug; 87(2):373-374.e5. PubMed ID: 35439607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [KI-basierte Bestimmung des PRO-Scores in aktinischen Keratosen anhand von LC-OCT-Bilddatensätzen: Artificial intelligence-based PRO score assessment in actinic keratoses from LC-OCT imaging using Convolutional Neural Networks].
    Thamm JR; Daxenberger F; Viel T; Gust C; Eijkenboom Q; French LE; Welzel J; Sattler EC; Schuh S
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1359-1368. PubMed ID: 37946638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study.
    Iglesias-Puzas Á; Conde-Taboada A; Campos-Muñoz L; Sirgado-Martínez A; López-Bran E
    Acta Derm Venereol; 2023 Oct; 103():adv15296. PubMed ID: 37876333
    [No Abstract]   [Full Text] [Related]  

  • 16. Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study.
    Kirchberger MC; Gfesser M; Erdmann M; Schliep S; Berking C; Heppt MV
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
    Schlesinger T; Stockfleth E; Grada A; Berman B
    Clin Cosmet Investig Dermatol; 2022; 15():2495-2506. PubMed ID: 36415541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland.
    Dymond A; Green W; Edwards M; Pont MAL; Gupta G
    Pharmacoecon Open; 2023 May; 7(3):443-454. PubMed ID: 37012513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison.
    Chiarello SE
    Dermatol Surg; 2000 Aug; 26(8):728-32. PubMed ID: 10940057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis.
    Gilaberte Y; Fernández-Figueras MT
    Actas Dermosifiliogr; 2022 Jan; 113(1):58-66. PubMed ID: 35249711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.